Abstract
Emerging concepts in the short term management of acute heart failure have fostered changes in therapeutic targets and the expectations of emergency department and in-hospital treatment options. Investigators and clinicians are now reconsidering how intravenous diuretics, vasodilators, and inotropes commonly used to alleviate congestion and restore hemodynamic stability should be administered; which acute heart failure patients should receive them; and the long-term morbidity and mortality implications of these decisions. This section evaluates these various therapeutic options for patients appropriate for short stay unit management.
Original language | English (US) |
---|---|
Pages (from-to) | 103-110 |
Number of pages | 8 |
Journal | Critical Pathways in Cardiology |
Volume | 7 |
Issue number | 2 |
DOIs | |
State | Published - Jun 2008 |
Externally published | Yes |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine